Literature DB >> 25926584

Life-threatening opioid toxicity from a fentanyl patch applied to eczematous skin.

Mhairi K Doris1, Euan A Sandilands2.   

Abstract

A 19-year-old man with a history of eczema was admitted to the emergency department following collapsing at home. The paramedics found him unresponsive with poor respiratory effort and a widespread erythematous rash. Anaphylaxis, thought to be secondary to flucloxacillin he had recently been prescribed, was diagnosed. Epinephrine, steroids and antihistamines were administered without clinical improvement. On arrival to hospital, constricted pupils were noted prompting the emergency physicians to consider opiate toxicity. Intravenous naloxone brought about an immediate recovery. His father subsequently disclosed that he had given his son one of his own fentanyl patches to alleviate the distressing symptoms of eczema. Although the patient had removed the patch prior to collapsing, he had suffered life-threatening opioid toxicity likely due to enhanced opiate absorption through eczematous skin. This case highlights the risks associated with fentanyl patches in patients with chronic skin conditions. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926584      PMCID: PMC4422925          DOI: 10.1136/bcr-2014-208945

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.

Authors:  Jesper Bo Nielsen; Flemming Nielsen; Jens Ahm Sørensen
Journal:  Arch Dermatol Res       Date:  2007-09-20       Impact factor: 3.017

Review 2.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket.

Authors:  M A Frölich; A Giannotti; J H Modell; M Frölich
Journal:  Anesth Analg       Date:  2001-09       Impact factor: 5.108

Review 4.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

5.  Life-threatening coma and full-thickness sunburn in a patient treated with transdermal fentanyl patches: a case report.

Authors:  Katia Sindali; Katie Sherry; Sankhya Sen; Baljit Dheansa
Journal:  J Med Case Rep       Date:  2012-07-26
  5 in total
  1 in total

Review 1.  Fentanyl Formulations in the Management of Pain: An Update.

Authors:  Stephan A Schug; Sonya Ting
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.